Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Squamous Intraepithelial Lesions 1Papillomavirus Infections 1Mucositis 1Hematologic Neoplasms 1HIV Infections 1Gallbladder Neoplasms 1Breast Carcinoma In Situ 1Bile Duct Neoplasms 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 6Vincristine 4Liposomes 4Bleomycin 4Fluorouracil 2sargramostim 1liposomal doxorubicin 1Zidovudine 1Watchful Waiting 1Radiotherapy 1Paclitaxel 1Observation 1Methotrexate 1Light Coagulation 1Leucovorin 1Laser Therapy 1Isotretinoin 1Imiquimod 1Dexamethasone 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Acquired Immunodeficiency Syndrome × Laser Therapy × Clear all
NCT02135419 2024-07-26

ANCHOR

AIDS Malignancy Consortium

Phase 3 Completed
4,446 enrolled 13 charts
GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡